Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Bladder Denervation vs Intramuscular Onabotulinum Toxin A for Refractory Overactive Bladder: A Randomized Comparative Study

NCT06796855 is registered in ClinicalTrials.gov with Bagcilar Training and Research Hospital as lead sponsor.

NCT NCT06796855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06796855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Bladder Denervation vs Intramuscular Onabotulinum Toxin A for Refractory Overactive Bladder: A Randomized Comparative Study
Lead sponsor
Bagcilar Training and Research Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2023
Completion date
February 1, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder syndrome, refractory overactive bladder